MedPath

SYMFI LO

These highlights do not include all the information needed to use safely and effectively. See full prescribing information for .  Initial U.S. Approval: 2018

Approved
Approval ID

86aad85d-5460-4c38-9761-a225e6bce190

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 15, 2019

Manufacturers
FDA

Mylan Specialty L.P.

DUNS: 194775557

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code49502-425
Application NumberNDA208255
Product Classification
M
Marketing Category
C73594
G
Generic Name
Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 9, 2019
FDA Product Classification

INGREDIENTS (14)

EFAVIRENZActive
Quantity: 400 mg in 1 1
Code: JE6H2O27P8
Classification: ACTIB
LAMIVUDINEActive
Quantity: 300 mg in 1 1
Code: 2T8Q726O95
Classification: ACTIB
TENOFOVIR DISOPROXIL FUMARATEActive
Quantity: 300 mg in 1 1
Code: OTT9J7900I
Classification: ACTIB
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 9XZ8H6N6OH
Classification: IACT
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SYMFI LO - FDA Drug Approval Details